Dr Nick Palmer (Liverpool Heart and Chest Hospital, Liverpool, UK) discusses the large multinational COMPLETE trial.
The aim of this comparative-effectiveness study was to determine whether routine angiographically-guided percutaneous coronary intervention (PCI) would prevent CV death or MI, compared with optimum guideline-directed medical therapy alone.
Filmed in London at BCIS ACI 2020.
Interviewer: Leiah Norcott
Videographer: Natacha Wienand / Dominic Woodruff
Key words:
Coronary Artery Disease
Myocardial Infarction
Infarction
Ischemia
Pathologic Processes
Necrosis
Coronary Disease
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Ticagrelor
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Purinergic P2 Receptor Antagonists
Purinergic Antagonists
Purinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs